Inner ear symptoms and disease: Pathophysiological understanding and therapeutic options

Medical Science Monitor

Volumn 19, Issue , 2013, Pages 1195-1210

  Ciuman, Raphael R ^a  

^a University Hospital   (Germany)

Author keywords

Genetic therapy; Inner ear disease; Meniere's disease; Sensorineural hearing loss; Stem cell therapy; Tinnitus; Vertigo

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR; ALPHA TOCOPHEROL; AQUAPORIN 4; ARLEVERT; ASCORBIC ACID; ATRIAL NATRIURETIC FACTOR; BETAHISTINE; CADHERIN 23; CINNARIZINE; CLAUDIN 11; CONNEXIN 26; CONNEXIN 30; CONNEXIN 31; DIMENHYDRINATE; GABAPENTIN; GAP JUNCTION PROTEIN; GLUCOCORTICOID; MEPROBAMATE; MINERALOCORTICOID; MUSCARINIC RECEPTOR; MYOSIN III; MYOSIN VIIA; PENDRIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PURINERGIC RECEPTOR; RADIXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE TRIPHOSPHATE; VASOPRESSIN;

DIZZINESS; ENDOLYMPH; GENE THERAPY; GENETIC DISORDER; HEARING DISORDER; HOMEOSTASIS; HUMAN; INNER EAR DISEASE; INNER EAR MALFORMATION; MENIERE DISEASE; NOISE; OTOTOXICITY; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; REVIEW; STEM CELL TRANSPLANTATION; SUDDEN DEAFNESS; TINNITUS; USHER SYNDROME; VERTIGO;

GENETIC THERAPY; HUMANS; LABYRINTH DISEASES; MODELS, BIOLOGICAL; OTOLARYNGOLOGY; STEM CELL TRANSPLANTATION;

EID: 84891063285     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889815     Document Type: Review

References (172)

1. Ménière P: Pathologie auriculaire: memoire sur des lesions de l'oreille interne donant lieu a des symptomes de congestion cerebrale apoplectiforme. Gaz Med, 1861; 16: 597-601 [in French]
2. Chung DY, Gannon RP, Mason K: Factors affecting the prevalence of tinnitus. Audiology, 1984; 23(5): 441-52
3. National Center for Health Statistics. Vital and Health Statistics, Series 11 No. 32. 1968: 1-28
4. Nadol JB Jr: Hearing loss. N Engl J Med, 1993; 329: 1092-102
5. Fortnum H, Summerfield A, Marshall D et al: Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ, 2001; 323: 536-40
6. Kemper AR, Down SM: A cost-effectiveness analysis of newborn hearing screening strategies. Arch Pediatr Adolesc Med, 2000; 154: 484-88
7. Cunningham M, Cox EO: Hearing assessment in infants and children: Recommendations beyond neonatal screening. Pediatrics, 2003; 111: 436-40
8. Morton CC, Nance WE: Newborn hearing screening: a silent revolution. N Engl J Med, 2006; 354: 2151-64
9. Gross M, Lange K, Spormann-Lagodzinski M: Congenital hearing loss in children. 2: Genetic hearing loss. HNO, 2001; 49: 602-17
10. Oezki M, Kato Z, Sasai H et al: Congenital inner ear malformations without sensorineural hearing loss in children. Int J Ped Otorhinolaryngol, 2009; 73: 1484-87
11. Jackler RK, Luxford WM, House WF: Congenital malformations of the inner ear: a classification based on embryogenesis. Laryngoscope, 1987; 97: 2-14
12. Sennaroglu L, Saatci I: A new classification for cochleovestibular malformations. Laryngoscope, 2002; 112: 2230-41
13. Giesemann AM, Kontorinis G, Zajaczek J et al: The vestibulocochlear nerve: aplasia and hypoplasia in combination with inner ear malformations. Eur Radiol, 2012; 22: 519-24
14. Marazita ML, Ploughman LM, Rawlings B et al: Genetic epidemiological studies of early-onset deafness in the U.S. School-age population. Am J Med Genet, 1993; 46: 486-91
15. Van Camp G, Smith RJH: Homepage on the Internet. Hereditary Hearing Loss Homepage. Available from: http//web01.ua.ac.be/hhh/
16. Friedman LM, Avraham KB: MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness. Mamm Genome, 2009; 20: 581-603
17. Mencia A, Modamio-Hoybjor S, Redshaw N et al: Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet, 2009; 41: 609-13
18. Drottar M, Liberman MC, Ratan RR, Roberson DW. The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs. Laryngoscope, 2006; 116: 292-96
19. Chen FQ, Schacht J, Sha SH: Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. J Neurochem, 2009; 108: 1226-36
20. Zelente L, Gasparini P, Estivill X et al: Connexin 26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet, 1997; 6: 1605-9
21. Estivill X, Fortina P, Surrey S et al: Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet, 1998; 351: 394-98
22. Kelley P, Harris D, Corner B et al: Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet, 1998; 62: 792-99
23. Gurtler N, Kim Y, Mhatre A et al: DFNA 54, a third locus for low-frequency hearing loss. J Mol Med, 2004; 82(11): 775-80
24. Verhoeven K, Van Laer L, Kirschhofer K et al: Mutations in the human alpha-tectorin gene cause autosomal dominant nonsyndromic hearing impairment. Nat Genet, 1998; 19(1): 60-62
25. McGuirt WT, Prasad SD, Griffith AJ et al: Mutations in COL11A2 cause nonsyndromic hearing loss (DFNA13). Nat Genet, 1999; 23: 413-19
26. Cryns K, Pfister M, Pennings R et al: Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations. Hum Genet, 2002; 110: 389-94
27. Delmaghani S, del Castillo FJ, Michel V et al: Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat Genet, 2006; 38: 770-78
28. Ciuman RR: Auditory and vestibular hair cell stereocilia: relationship between functionality and inner ear disease. J Laryngol Otol, 2011; 125: 991-1003
29. Kimberling WJ, Moller C: Clinical and molecular genetics of Usher syndrome. J Am Acad Audiol, 1995; 6: 63-72
30. Bougham JA, Vernon M, Shaver KA: Usher syndrome: definition and estimate of prevalence from two high risk populations. J Chron Dis, 1983; 36: 595-603
31. Vernon M: Usher syndrome-deafness and progressive blindness. Clinical cases, prevention, theory and literature survey. J Chron Dis, 1969; 22: 133-51
32. Otterstede CR, Spandau U, Blankenagel A et al: A new clinical classification for Usher's syndrome based on a new subtype of Usher's syndrome type 1. Laryngoscope, 2001; 111: 84-86
33. Ciuman RR: Communication routes between intracranial spaces and inner ear; function, pathophysiologic importance and relations with inner ear diseases. Am J Otolaryngol, 2009; 30: 193-202
34. Swartz JD: An overview of congenital/developmental sensorineural hearing loss with emphasis on the vestibular aqueduct syndrome. Semin Ultrasound CT MR, 2004; 25: 353-68
35. Reardon W, Omahoney CF, Trembath R et al: Enlarged vestibular aqueduct: a radiological marker of Pendred syndrome, and mutation of the PDS gene. QJM, 2000; 93: 99-104
36. Everett LA, Glaser B, Beck JC et al: Pendred syndrome is caused by mutations in a punative sulphate transporter gene (PDS). Nat Genet, 1997; 17: 411-22
37. Chen K, Wang X, Sun L, Jiang H: Screening of SLC26A4, FOXI1, KCNJ10, and GJB2 in bilateral deafness patients with inner ear malformation. Otolaryngol Head Neck Surg, 2012; 146: 972-78
38. Propst EJ, Blaser S, Stockley TL et al: Temporal bone imaging in GJB2 deafness. Laryngoscope, 2006; 116: 2178-86
39. Ciuman RR: Stria vascularis and vestibular dark cells: characterisation of main structures responsible for inner-ear homeostasis, and their pathophysiological relations. J Laryngol Otol, 2009; 123: 151-62
40. Gratton MA, Rao VH, Meehan DT et al: Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology. Am J Pathol, 2005; 166: 1465-74
41. Hawkins JE Jr: Microcirculation in the labyrinth. Arch Otorhinolaryngol, 1976; 212: 241-51
42. Castaldo A, Linthicum FH Jr: Stria vascularis hearing loss. Otol Neurotol, 2006; 27: 285-86
43. Schuknecht HF: Pathology of the ear. 2nd ed. Malvern (PA): Lea & Febiger, 1993
44. Johnsson LG, Hawkins JE Jr: Sensory and neural degeneration with aging, as seen in microdissection in the human inner ear. Ann Otol Rhinol Laryngol, 1972; 81: 179-93
45. Nadol JB Jr: Electron microscopic findings in presbyacusic degeneration of the basal turn of the cochlea. Otolaryngol Head Neck Surg, 1979; 87: 818-36
46. Thomopoulos GN, Spicer SS, Gratton MA, Schulte BA: Age-related thickening of basement membrane in stria vascularis capillaries. Hear Res, 1997; 111: 31-41
47. Löwenheim H, Hirt B: Aquaporine. Discovery, function, and significance for otorhinolaryngology. HNO, 2004; 52(8): 673-78
48. Beitz E, Kumagami H, Krippeit-Drews P et al: Expression pattern of aquaporin water channels in the inner ear of the rat. The molecular basis for a water regulation system in the endolymphatic sac. Hear Res, 1999; 132: 76-84
49. Beitz E, Zenner HP, Schultz JE: Aquaporin-mediated fluid regulation in the inner ear. Cell Mol Neurobiol, 2003; 23: 315-29
50. Huang D, Chen P, Chen S et al: Expression patterns of aquaporins in the inner ear: evidence for concerted actions of multiple types of aquaporins to facilitate water transport in the cochlea. Hear Res, 2002; 165: 85-95
51. Ciuman RR: The efferent system or olivocochlear function bundle-fine regulator and protector of hearing perception. Int J Biomed Sci, 2010; 4: 276-88
52. Oestreicher E, Wolfgang A, Felix D: Neurotransmission of the cochlear inner hair cell synapse-implications for inner ear therapy. Adv Otorhinolaryngol, 2002; 59: 131-39
53. Schrott-Fischer A, Kammen-Jolly K, Scholtz A et al: Efferent neurotransmission in the human cochlea and vestibule. Acta Otolaryngol, 2007; 127: 13-19
54. Puel JL: Chemical synaptic transmission in the cochlea. Prog Neurobiol, 1995; 47: 449-76
55. Pujol R, Puel JL, D'Aldin C, Eybalin M: Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol, 1993; 113: 330-34
56. D'Aldin C, Puel JL, Leducq R et al: Effects of a dopaminergic agonist in the guinea pig cochlea. Hear Res, 1995; 90: 202-11
57. D'Aldin C, Eybalin M, Puel JL et al: Synaptic connections and putative functions of the dopaminergic innervation of the guinea pig cochlea. Eur Arch Otorhinolaryngol, 1995; 252: 270-74
58. Halmos G, Doleviczenyi Z, Repassy G et al: D2 autoreceptor inhibition reveals oxygen-glucose deprivation-induced release of dopamine in guineapig cochlea. Neuroscience, 2005; 132(3): 801-9
59. Maison SF, Luebke, AF, Liberman MC, Zuo J: Efferent protection from acoustic injury is mediated via alpha9 nicotinic acetylcholine receptors on outer hair cells. J Neurosci, 2002; 22(24): 10838-46
60. Strominger RN, Bohne BA, Harding GW: Regenerated nerve fibers in the noise-damaged chinchilla cochlea are not efferent. Hear Res, 1995; 92(1-2): 52-62
61. Schmidt PH, Brunsting, RC, Antvelink JB: Meniere's disease: etiology and natural history. Acta Otolaryngol, 1979; 87: 410-12
62. Haye R, Quist-Hanssen SV: The natural course of Meniere's disease. Acta Otolaryngol, 1976; 82: 289-93
63. Hallpike CS, Cairns H: Observations on the pathology of Meniere's syndrome. J Laryngol Otol, 1938; 53: 625-55
64. Yamakawa K: Über die pathologische Veränderung bei einem Meniere-Kranken. Z Otol, 1938; 11: 192-93
65. Merchant SN, Adams JC, Nadol JB Jr: Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol, 2005; 26: 74-81
66. Gürkov R, Flatz W, Louza J et al: In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Meniere's disease. Otol Neurotol, 2012; 33: 1040-45
67. Arweiler DJ, Jahnke K, Grosse-Wilde H: Meniere disease as an autosomal dominant hereditary disease. Laryngorhinootologie, 1995; 74: 512-15
68. Altermatt HJ, Gebbers JO, Müller C et al: Human endolymphatic sac: Evidence for a role in inner ear immune defence. ORL J Otorhinolaryngol Relat Spec, 1990; 52: 143-48
69. Tomiyama S, Harris JP: The endolymmphatic sac: its importance in inner ear immune responses. Laryngoscope, 1986; 96: 685-91
70. Tomiyama S, Kinoshita T, Jinnouchi K: Fluctuating hearing loss following immune reaction in the endolymphatic sac of guinea pigs. ORL J Otorhinolaryngol Relat Spec, 1995; 57: 122-28
71. Manni JJ, Kuijpers W: Longitudinal flow of macromolecules in the endolymphatic space of the rat: An autoradiographical study. Hear Res, 1987; 26: 229-37
72. Thalmann R, Thalmann I: Source and role of endolymph macromolecules. Acta Otolaryngol, 1999; 119: 293-96
73. Ikeda M, Sando I: Endolymphatic duct and sac in patients with Meniere's disease. Ann Otol Rhinol Laryngol, 1984; 93: 540-46
74. Lim DJ, Glasscock ME: Fine morphology of the endolymphatic sac in Meniere's disease. In: Vosteen KH, Schuknecht H, Pfaltz CR et al., (eds.), Meniere's disease. Pathogenesis, Diagnosis and treatment. New York: Georg Thieme Verlag, 1981; 115
75. Arenberg IK, Marovitz WF, Shambaugh GE: The role of the endolymphatic sac in the pathogenesis of endolymphatic hydrops in man. Acta Otolaryngol Suppl, 1970; 275: 1-49
76. Saito H, Kitahara M, Yazawa Y, Matsumoto M: Histopathologic findings in surgical specimens of endolymphatic sac in Meniere's disease. Acta Otolaryngol, 1977; 83: 465-69
77. Yasawa Y, Kitahara M: Electron microscopic studies of the endolymphatic sac in Meniere's disease. ORL J Otorhinolaryngol Relat Spec, 1981; 43: 121-30
78. Shambaugh GE Jr: Surgery of the endolymphatic sac. Arch Otolaryngol, 1966; 83: 305-15
79. Xenellis JE, Linthicum FH Jr, Webster P, Lopez R: Basilar membrane displacement related to endolymphatic sac volume. Laryngoscope, 2004; 114(11): 1953-59
80. Zhong SX, Liu ZH: Expression of aquaporins in the cochlea and endolymmphatic sac of guinea pig. ORL J Otorhinlaryngol Relat Spec, 2003; 65: 284-89
81. Fukushima M, Kitahara T, Fuse Y: Changes in aquaporin expression in the inner ear of the rat after i.p. injection of steroids. Acta Otolaryngol Suppl, 2004; 553: 13-18
82. Takeada T, Takeda S, Kitano H et al: Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res, 2000; 140: 1-6
83. Kumagami H, Löwenheim H, Beitz E et al: The effect of antidiuretic hormone on the endolymphatic sac and the inner ear. Pflugers Arch, 1998; 436: 970-75
84. Kitahara T, Fukushima M, Uno Y et al: Up-regulation of cochlear aquaporin-3 mRNA after intra-endolymphatic sac application of dexamethasone. Neurol Res, 2003; 25: 865-70
85. Fukushima M, Kitahara T, Uno Y et al: Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression. Acta Otolaryngol, 2002; 122: 600-6
86. Dunnebier EA, Segenhout JM, Wit HP, Albers FW: Two-phase endolymphatic hydrops: a new dynamic guinea pig model. Acta Otolaryngol, 1997; 117: 13-19
87. Wilson WR, Byl FM, Laird N: The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Acta Otolaryngol, 1980; 106: 772-76
88. Görür K, Tuncer U, Eskandari G et al: The role of factor V Leiden and prothrombin G20210A mutations in sudden sensorineural hearing loss. Otol Neurotol, 2005; 599-601
89. Capaccio P, Ottaviani F, Cuccarini V et al: Sudden hearing loss and MTHFR 677C>t/1298A>C gene polymorphisms. Genet Med, 2005; 7: 206-8
90. Rudack C, Langer C, Stoll W et al: Vascular risk factors in sudden hearing loss. Thromb Haemost, 2006; 95: 454-61
91. Capaccio P, Cuccarini V, Ottaviani F et al: Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic disease. Ann Otol Rhinol Laryngol, 2009; 118: 205-10
92. Byl FM Jr: Sudden hearing loss: Eight years experience and suggested prognostic table. Laryngoscope, 1984; 94: 647-61
93. Fetterman BL, Saunders JE, Luxford WM: Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol, 1996; 17: 529-36
94. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME: Sudden sensorineural hearing loss. Otolaryngol Clin North Am, 1996; 29: 393-405
95. Mattox DE, Simmons FB: Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol, 1977; 86: 463-80
96. Ziegler EA, Hohlweg-Majert B, Maurer J, Mann WJ: Epidemiological data of patients with sudden hearing loss-a retrospective study over a period of three years. Laryngorhinootologie, 2003; 82: 4-8
97. Sakagami M, Sano M, Tamaki H, Matsunaga T: Ultrastructural study of effect of acute hyper-and hypotension on the stria vascularis and spiral ligament. Acta Otolaryngol Suppl, 1984; 406: 256-62
98. Suckfüll M: Fibrinogen and LSL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet, 2002; 360: 1811-17
99. Cesarone MR, Incandela L, Belcaro G et al: Treatment of vascular inner ear disease in vascular patients with pentoxifylline: a controlled, randomized trial. Angiology, 2002; 53(Suppl.1): S23-26
100. Gyo K: Experimental study of transient cochlear ischemia as a cause of sudden deafness. World J Otorhinlaryngol, 2013; 3: 1-15
101. Tadros SF, D'Souza M, Zhu X, Frisina RD: Apoptosis-related genes change their expression with age and hearing loss in the mouse cochlea. Apoptosis, 2008; 13: 1303-21
102. Sha SH, Chen FQ, Schacht J: PTEN attenuates PIP3/Akt signaling in the cochlea of the aging CBA/J mouse. Hear Res, 2010; 264: 86-92
103. Yamane H, Nakai Y, Takayama M et al: Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Eur Arch Otorhinolaryngol, 1995; 252: 504-8
104. Yamashita D, Jiang HY, Schacht J, Miller JM: Delayed production of free radicals following noise exposure. Brain Res, 2004; 1019: 201-9
105. Fridberger A, Flock A, Ulfendahl M, Flock B: Acoustic overstimulation increases outer hair cell Ca2+ concentrations and causes dynamic concentrations of the hearing organ. Proc Natl Acad Sci USA, 1998; 95: 7127-32
106. Orrenius S, Zhivotovsky B, Nicotera P: Regulation of cell death: the calcium-apoptosis links. Nat Rev Mol Cell Biol, 2003; 4: 552-65
107. Thorne PR, Nuttall AL: Laser Doppler measurements of cochlear blood flow during loud sound exposure in the guinea pig. Hear Res, 1987; 27: 1-10
108. Ohinata Y, Miller JM, Altschuler RA, Schacht J: Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea. Brain Res, 2000; 878: 163-73
109. Abaamrane L, Raffin F, Gal M et al: Long-term administration of magnesium after acoustic trauma caused by gunshot noise in guinea pigs. Hear Res, 2009; 247: 137-45
110. Attias J, Weisz G, Almong S et al: Oral magnesium intake reduces permanent hearing loss induced by noise exposure. Am J Otolaryngol, 1994; 15: 26-32
111. Davis RR, Kozel P, Erway LC: Genetic influences in individual susceptibility to noise: a review. Noise Health, 2003; 5: 19-28
112. Takumida M, Fredelius L, Bagger-Sjoback D et al: Effect of acoustic overstimulation on the glycocalyx and the ciliary interconnections in the organ of Corti: high resolution scanning electron microscopic investigation. J Laryngol Otol, 1989; 103: 1125-29
113. Takumida M, Urquiza R, Bagger-Sjoback D, Wersall J: Effect of gentamicin on the carbohydrates of the vestibular end organs: an investigation by the use of FITC-lectins. J Laryngol Otol, 1989; 103: 357-62
114. Takumida M, Bagger-Sjoback D, Wersall J, Harada Y: The effect of gentamicin on the glycocalyx and the ciliary interconnections in vestibular sensory cells: a high resolution scanning electron microscopic investigation. Hear Res, 1989; 37: 163-70
115. Schwaber MK: Medical evaluation of tinnitus. Otolaryngol Clin North Am, 2003; 36: 287-92
116. Prezant TR Agapian JV, Bohlman MC et al: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet, 1993; 4: 289-94
117. Fischel-Ghodsian N: Genetic factors in aminoglycoside toxicity. Pharmagenomics, 2005; 6: 27-36
118. Feldman L, Efrati S, Eviatar E et al: Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. Kidney Int, 2007; 72: 359-63
119. Sha SH, Qiu JH, Schacht J: Aspirin to prevent gentamicin-induced hearing loss. N Engl J Med, 2006; 354: 1856-57
120. Suckfuell M, Canis M, Strieth S et al: Intratympanic treatment of acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol, 2007; 127: 938-42
121. Lynch ED, Kil J: Compounds for the prevention and treatment of noise-induced hearing loss. Drug Discov Today, 2005; 10: 1291-98
122. Rybak LP, Whitworth CA: Ototoxicity: therapeutic opportunities. Drug Discov Today, 2005; 10: 1313-21
123. Ohlemiller KK: Recent findings and emerging questions in cochlear noise injury. Hear Res, 2008; 245: 5-17
124. Oishi N, Schacht J: Emerging treatments for noise-induced hearing loss. Expert Opin Emerg Drugs, 2011; 16: 235-45
125. Tabuchi K, Nishimura B, Nakamagoe M et al: Ototoxicity: mechanisms of cochlear impairment and its prevention. Curr Med Chem, 2011; 18: 4866-71
126. Lin CY, Wu JL, Shih TS et al: N-Acetyl-cysteine against noise-induced temporary threshold shift in male workers. Hear Res, 2010; 269: 42-47
127. Kang HS, Park JJ, Ahn SK et al: Effect of high dose intravenous vitamin C on idiopathic sudden sensorineural hearing loss: a prospective single-blind randomized controlled trial. Eur Arch Otorhinolaryngol, 2013; 270: 2631-36
128. Hatano M, Uramoto N, Okabe Y et al: Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol, 2008; 128: 116-21
129. Angell SI, Abi-Hachem RN, Vivero RJ et al: L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. Acta Otolaryngol, 2012; 132: 369-76
130. Novotny M, Kostrica R: Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Meniere's disease: a randomized, doubleblind, parallel group clinical study. Int Tinnitus J, 2002; 8: 115-23
131. Claes J, Van de Heyning PH: Medical treatment of Meniere's disease: a review of literature. Acta Otolaryngol Suppl, 1997; 526: 37-42
132. Cohen-Kerem R, Kisilevsky V, Einarson TR et al: Intratympanic gntamicin for Meniere's disease. A meta-analysis. Laryngoscope, 2004; 114: 2085-91
133. Raponi G, Alpini D, Volonte S et al: The role of free radicals and plasmatic antioxidant in Meniere's syndrome. Int Tinnitus J, 2003; 9: 104-8
134. Takumida M, Anniko M, Ohtani M: Radical scavengers for Meniere's disease after failure of conventional therapy. A pilot study. Acta Otolaryngol, 2003; 123: 697-703
135. Walther LE: Procedures for restoring vestibular disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2005; 4: Doc05
136. Hamann K: Special Gingko extract in cases of vertigo: a systematic review of randomised, double-blind, placebo-controlled clinical examinations. HNO, 2007; 258-63
137. Von Wedel H, Von Wedel UC: An assessment of tinnitus retraining therapy. HNO, 2000; 48: 887-901
138. Marano RJ, Redmond SL: In vitro cultured primary cells from a human utricle explant possesses hair cell like characteristics. J Mol Histol, 2011; 42: 365-70
139. Hu Z: A stem cell based replacement for the inner ear. J Otology Rhinology [serial online] 2012; 1(1)
140. Zuliani GF: Stem cell based regenerative medicine: What is science? What is fiction? And what is science fiction? J Otology Rhinology [serial online] 2012; 1(1)
141. Oshima K, Shin K, Diensthuber M et al: Mechanosensitive hair cell-like embryonic and induced pluripotent stem cells. Cell, 2010; 141: 704-16
142. Koehler KR, Mikosz AM, Molosh AI et al: Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture. Nature, 2013; 500: 217-21
143. Duran Alonso MB, Fejoo-Redondo A, Conde de Felipe M et al: Generation of inner ear sensory cells from bone marrow-derived human mesenchymal stem cells. Regen Med, 2012; 7: 769-83
144. Boddy SL, Chen W, Romero-Guevara R et al: Inner ear progenitor cells can be generated in vitro from human bone marrow mesenchymal stem cells. Regen Med, 2012; 7: 757-67
145. Yuan XD, Yan X, Yang H et al: In vitro study of directional inducible differentiation of inner hair cells from human adipose-derived mesenchymal stem cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2009; 44: 323-28
146. Mosna F, Sensebe L, Krampera M: Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev, 2010; 19: 1449-70
147. Bermingham NA, Hassan BA, Price SD et al: Math1: an essential gene for the generation of inner ear hair cells. Science, 1999; 284: 1837-41
148. Chen P, Johnson JE, Zoghbi HY, Segil N: The role of Math1 in inner ear development: uncoupling the establishment of the sensory primordium from hair cell fate determination. Development, 2002; 129: 2495-505
149. Zheng JL, Gao WQ: Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci, 2000; 3: 580-86
150. Kawamoto K, Ishimoto S, Minoda R et al: Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci, 2003; 23: 4395-400
151. Shou J, Zheng JL, Gao WQ: Robust generation of new hair cells in the mature mammalian inner ear by adenoviral expression of Hath1. Mol Cell Neurosci, 2003; 23: 169-79
152. Izumikawa M, Minoda R, Kawamoto K et al: Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med, 2005; 11: 271-76
153. Mukherjea D, Jajoo S, Whitworth et al: Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci, 2008; 28: 13056-65
154. Mukherjea D, Jajoo S, Kaur T et al: Transtympanic administration of short interfering siRNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal, 2010; 13: 589-98
155. Pfannenstiel SC, Praetorius M, Plinkert PK et al: Bcl-2 gene therapy prevents aminoglycoside-induced degeneration of auditory and vestibular hair cells. Audiol Neurootol, 2009; 14: 254-66
156. Yagi M, Magal E, Sheng Z et al: Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther, 1999; 10: 813-23
157. Kawamato K, Yagi M, Stover T et al: Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther, 2003; 7: 484-92
158. Cooper LB, Chan DK, Roediger FC et al: AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol Neurotol, 2006; 27: 484-90
159. Liu Y, Okada T, Simzaki K et al: Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea. Mol Ther, 2008; 16: 474-80
160. Ahmad S, Tang W, Chang Q et al: Restoration of connexin 26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci USA, 2007; 104: 1337-41
161. Akil O, Seal RP, Burke K et al: Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron, 2012; 75: 283-93
162. Maeda Y, Fukushima K, Nishizaki K, Smith RJ: In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet, 2005; 14: 1641-50
163. Raper SE, Chirmule N, Lee FS et al: Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab, 2003; 80: 148-58
164. Thomas CE, Erhardt A, Kay MA: Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet, 2003; 4: 148-58
165. Chen G, Zhang X, Yang F, Mu L: Disposition of nanoparticle-based delivery system via inner ear administration. Curr Drug Metab, 2010; 11: 886-97
166. Wareing M, Mhatre AN, Pettis R et al: Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res, 1999; 128: 61-69
167. Buckiova D, Ranjan S, Newman TA et al: Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane. Nanomedicine (Lond), 2012; 7: 1339-54
168. Ge X, Jackson RL, Liu J, et al: Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol Head Neck Surg, 2007; 137: 619-23
169. Tamura T, Kita T, Nakagawa T et al: Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope, 2005; 115: 2000-5
170. Goycoolea MV: Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol, 2001; 121: 437-47
171. Kabanov AV, Vinogradov SV: Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed Engl, 2009; 48: 5418-29
172. Kim A, Pykko I: Size matters: versatile use of PiggyBac transposons as a genetic manipulation tool. Mol Cell Biochem, 2011; 354: 301-9